Table 2.
Surgical outcomes
| Variable | Sorafenib | Control | P value2 |
| Type of resection | - | ||
| Minor | 8 | 16 | |
| Major3 | 26 | 52 | |
| Intraoperative blood loss, mL1 | 350 (50-1600) | 380 (50-1800) | 0.132 |
| Intraoperative blood transfusion, mL1 | 650 (0-1500) | 600 (0-1600) | 0.126 |
| No. of patients without transfusion, % | 31 (75.0%) | 58 (81.48%) | 0.139 |
| Postoperative AST on day 3, IU/L1 | 226 (48-896) | 327 (68-1237) | 0.042 |
| Postoperative total bilirubin on day 3, mmol/L1 | 42 (19-276) | 39 (18-212) | 0.138 |
| Infectious morbidity | 8 | 12 | 0.566 |
| Lung infection | 3 | 4 | |
| Abdominal collection | 4 | 6 | |
| Infection of incisional wound | 1 | 1 | |
| Sepsis | 0 | 1 | |
| Noninfectious morbidity | 4 | 9 | 0.853 |
| Pleural effusion | 3 | 5 | |
| Bile leak | 1 | 4 | |
| Liver failure | 0 | 0 |
1
Value expressed in median with range in parentheses;
2
Study group compared with control group;
3
Major hepatectomy was defined as resection of three or more segments.